Literature DB >> 15964819

Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia.

S L Masters1, K R Palmer, W S Stevenson, D Metcalf, E M Viney, N S Sprigg, W S Alexander, N A Nicola, S E Nicholson.   

Abstract

The SSB family is comprised of four highly homologous proteins containing a C-terminal SOCS box motif and a central SPRY domain. No function has yet been ascribed to any member of this family in mammalian species despite a clear role for other SOCS proteins in negative regulation of cytokine signaling. To investigate its physiological role, the murine Ssb-2 gene was deleted by homologous recombination. SSB-2-deficient mice were shown to have a reduced rate of platelet production, resulting in very mild thrombocytopenia (25% decrease in circulating platelets). Tissue histology and other hematological parameters were normal, as was the majority of serum biochemistry, with the exception that blood urea nitrogen (BUN) levels were decreased in mice lacking SSB-2. Quantitative analysis of SSB mRNA levels indicated that SSB-1, -2, and -3 were ubiquitously expressed; however, SSB-4 was only expressed at very low levels. SSB-2 expression was observed in the kidney and in megakaryocytes, a finding consistent with the phenotype of mice lacking this gene. Deletion of SSB-2 thus perturbs the steady-state level of two tightly controlled homeostatic parameters and identifies a critical role for SSB-2 in regulating platelet production and BUN levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964819      PMCID: PMC1156973          DOI: 10.1128/MCB.25.13.5639-5647.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

Authors:  S E Nicholson; D De Souza; L J Fabri; J Corbin; T A Willson; J G Zhang; A Silva; M Asimakis; A Farley; A D Nash; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Thrombopoietin in vitro and in vivo.

Authors:  W S Alexander; C G Begley
Journal:  Cytokines Cell Mol Ther       Date:  1998-03

3.  Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.

Authors:  A W Roberts; L Robb; S Rakar; L Hartley; L Cluse; N A Nicola; D Metcalf; D J Hilton; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Functional analysis of Asb-1 using genetic modification in mice.

Authors:  B T Kile; D Metcalf; S Mifsud; L DiRago; N A Nicola; D J Hilton; W S Alexander
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.

Authors:  S Kimura; A W Roberts; D Metcalf; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 6.  The function and regulation of vasa-like genes in germ-cell development.

Authors:  E Raz
Journal:  Genome Biol       Date:  2000-09-01       Impact factor: 13.583

7.  The mouse homolog of Drosophila Vasa is required for the development of male germ cells.

Authors:  S S Tanaka; Y Toyooka; R Akasu; Y Katoh-Fukui; Y Nakahara; R Suzuki; M Yokoyama; T Noce
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

8.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1.

Authors:  R Starr; D Metcalf; A G Elefanty; M Brysha; T A Willson; N A Nicola; D J Hilton; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  P-Selectin and platelet clearance.

Authors:  G Berger; D W Hartwell; D D Wagner
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

10.  Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ "knock-in" strategy.

Authors:  A G Elefanty; C G Begley; D Metcalf; L Barnett; F Köntgen; L Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more
  6 in total

1.  Dynamics of the SPRY domain-containing SOCS box protein 2: flexibility of key functional loops.

Authors:  Shenggen Yao; Ming S Liu; Seth L Masters; Jian-Guo Zhang; Jeffrey J Babon; Nicos A Nicola; Sandra E Nicholson; Raymond S Norton
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

2.  SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.

Authors:  Sheng Liu; Thao Nheu; Rodney Luwor; Sandra E Nicholson; Hong-Jian Zhu
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

3.  The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.

Authors:  Zhihe Kuang; Rowena S Lewis; Joan M Curtis; Yifan Zhan; Bernadette M Saunders; Jeffrey J Babon; Tatiana B Kolesnik; Andrew Low; Seth L Masters; Tracy A Willson; Lukasz Kedzierski; Shenggen Yao; Emanuela Handman; Raymond S Norton; Sandra E Nicholson
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

Review 4.  Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor.

Authors:  Hanshen Tae; Marco G Casarotto; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-04-28       Impact factor: 1.733

5.  Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4.

Authors:  Panagis Filippakopoulos; Andrew Low; Timothy D Sharpe; Jonas Uppenberg; Shenggen Yao; Zhihe Kuang; Pavel Savitsky; Rowena S Lewis; Sandra E Nicholson; Raymond S Norton; Alex N Bullock
Journal:  J Mol Biol       Date:  2010-06-16       Impact factor: 5.469

6.  Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.

Authors:  Francesc Vidal; Miguel López-Dupla; Montserrat Laguno; Sergi Veloso; Josep Mallolas; Javier Murillas; Carmen Cifuentes; Lluis Gallart; Teresa Auguet; Gloria Sampériz; Antoni Payeras; Pilar Hernandez; Mireia Arnedo; Josep Ma Gatell; Cristóbal Richart
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.